Detection of chymase-digested C-terminally truncated apolipoprotein A-I in normal human serum

Journal of Immunological Methods

Volumn 369, Issue 1-2, 2011, Pages 51-58

  Usami, Yoko ^a   Matsuda, Kazuyuki ^b   Sugano, Mitsutoshi ^b   Ishimine, Nau ^b   Kurihara, Yuriko ^a   Sumida, Tamaki ^a   Yamauchi, Kazuyoshi ^c   Tozuka, Minoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Atherosclerosis; Biomarker; Mast cell; Monoclonal antibody; Proteolysis; Reverse cholesterol transport

Indexed keywords

16 4 MONOCLONAL ANTIBODY; APOLIPOPROTEIN A1; C TERMINALLY TRUNCATED APOLIPOPROTEIN A1; CHYMASE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AFFINITY CHROMATOGRAPHY; ARTICLE; HUMAN; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; SERUM; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; ANTIBODIES, MONOCLONAL; APOLIPOPROTEIN A-I; BLOTTING, WESTERN; CHROMATOGRAPHY, AFFINITY; CHYMASES; HUMANS;

MUS;

EID: 79958858111     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.04.002     Document Type: Article

References (32)

1. Brouillette C.G., Dong W., Yang Z.W., Ray M.J., Protasevich I.I., Cheung H.C., Engler J.A. Förster resonance energy transfer measurements are consistent with a helical bundle model for lipid-free apolipoprotein A-I. Biochemistry 2005, 44:16,413-16,425.
2. Eberini I., Gianazza E., Breghi L., Klugmann S., Calabresi L., Gomaraschi M., Mombelli G., Brusoni B., Wait R., Sirtori C.R. Apolipoprotein A-I breakdown is induced by thrombolysis in coronary patients. Ann. Med. 2007, 39:306-311.
3. Favari E., Lee M., Calabresi L., Franceschini G., Zimetti F., Bernini F., Kovanen P.T. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein. J. Biol. Chem. 2004, 279:9930-9936.
4. Ghiselli G., Rohde M.F., Tanenbaum S., Krishnan S., Gotto A.M. Origin of apolipoprotein A-I polymorphism in plasma. J. Biol. Chem. 1985, 260:15,662-15,668.
5. Greaves D.R., Gordon S. Recent insights into the biology of macrophage scavenger receptors. J. Lipid Res. 2005, 46:11-20.
6. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34:1345-1353.
7. Ishimine N., Usami Y., Nogi S., Sumida T., Kurihara Y., Matsuda K., Nakamura K., Yamauchi K., Okumura N., Tozuka M. Identification of N-homocysteinylated apolipoprotein AI in normal human serum. Ann. Clin. Biochem. 2010, 47:453-459.
8. Jessup W., Gelissen I.C., Gaus K., Kritharides L. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr. Opin. Lipidol. 2006, 17:247-257.
9. Judström I., Jukkola H., Metso J., Jauhiainen M., Kovanen P.T., Lee-Rueckert M. Mast cell-dependent proteolytic modification of HDL particles during anaphylactic shock in the mouse reduces their ability to induce cholesterol efflux from macrophage foam cells ex vivo. Atherosclerosis 2010, 208:148-154.
10. Kaartinen M., Penttila A., Kovanen P. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994, 90:1669-1678.
11. Kelley J.L., Chi D.S., Abou-Auda W., Smith J.K., Krishnaswamy G. The molecular role of mast cells in atherosclerotic cardiovascular disease. Mol. Med. Today 2000, 6:304-308.
12. Koenig W. Cardiovascular biomarkers: added value with an integrated approach?. Circulation 2007, 116:3-5.
13. Koyama M., Tanaka M., Dhanasekaran P., Lund-Katz S., Phillips M.C., Saito H. Interaction between the N- and C-terminal domains modulates the stability and lipid binding of apolipoprotein A-I. Biochemistry 2009, 48:2529-2537.
14. Krishnaswamy G., Kelley J., Johnson D., Youngberg G., Stone W., Huang S.K., Bieber J., Chi D.S. The human mast cell: functions in physiology and disease. Front. Biosci. 2001, 6:D1109-D1127.
15. Lee M., Uboldi P., Giudice D., Catapano A.L., Kovanen P.T. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase: implications for HDL function. J. Lipid Res. 2000, 41:975-984.
16. Lee M., Calabresi L., Chiesa G., Franceschini G., Kovanen P.T. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1475-1481.
17. Lee M., Sommerhoff C.P., Eckardstein A.V., Zettl F., Fritz H., Kovanen P.T. Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol. Arterioscler. Thromb. Vasc. Biol. 2002, 22:2086-2091.
18. Lee M., Kovanen P.T., Tedeschi G., Oungre E., Franceschini G., Calabresi L. Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux. J. Lipid Res. 2003, 44:539-546.
19. Lee M., Vikstedt R., Metso J., Jauhiainen M., Kovanen P.T. Association of cholesteryl ester transfer protein with HDL particles reduces its proteolytic inactivation by mast cell chymase. J. Lipid Res. 2008, 49:358-368.
20. Lindstedt L., Kovanen P.T. Plasmin and kallikrein reduce HDL-induced cholesterol efflux from foam cells. Biochem. Biophys. Res. Commun. 2000, 277:552-557.
21. Lindstedt L., Saarinen J., Kalkkinen N., Welgus H., Kovanen P.T. Matrix metalloproteinases-3, -7, and -12, but Not -9, reduce high density lipoprotein-induced cholesterol efflux from human macrophage foam cells by truncation of the carboxyl terminus of apolipoprotein A-I. Parallel losses of pre-beta particles and the high affinity component of efflux. J. Biol. Chem. 1999, 274:22,627-22,634.
22. Liz M.A., Gomes C.M., Saraiva M.J., Sousa M.M. ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity. J. Lipid Res. 2007, 48:2385-2395.
23. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
24. Navab M., Berliner J.A., Watson A.D., Hama S.Y., Territo M.C., Lusis A.J., Shih D.M., van Lenten B.J., Frank J.S., Demer L.L., Edwards P.A., Fogelman A.M. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler. Thromb. Vasc. Biol. 1996, 16:831-842.
25. Paananen K., Kovanen P.T. Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules. J. Biol. Chem. 1994, 269:2023-2031.
26. Packard R.R.S., Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin. Chem. 2007, 54:24-38.
27. Pineda J., Marin F., Marco P., Roldan V., Valencia J., Ruiz-Nodar J.M., Romero D.H., Sogorb F., Lip G.Y. The prognostic value of biomarkers after a premature myocardial infarction. Int. J. Cardiol. 2010, 143:249-254.
28. Shao B., Oda M.N., Bergt C., Fu X., Green P.S., Brot N., Oram J.F., Heinecke J.W. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. J. Biol. Chem. 2006, 281:9001-9004.
29. Shao B., Oda M.N., Oram J.F., Heinecke J.W. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Curr. Opin. Cardiol. 2006, 21:322-328.
30. Tabas I. Nonoxidative modifications of lipoproteins in atherogenesis. Annu. Rev. Nutr. 1999, 19:123-139.
31. Vedhachalam C., Duong P.T., Nickel M., Nguyen D., Dhanasekaran P., Saito H., Rothblat G.H., Lund-Katz S., Phillips M.C. Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles. J. Biol. Chem. 2007, 282:25,123-25,130.
32. Wang N., Silver D.L., Thiele C., Tall A.R. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 2001, 276:23,742-23,747.